Podcast Episodes

Back to Search
Special Report: One on One with Sofinnova’s Papiernik
Special Report: One on One with Sofinnova’s Papiernik

Season 1

6 years, 4 months ago

Short Long
View Episode
Ep. 13 - Nuances of NASH, COVID Vaccines and Real-World Data
Ep. 13 - Nuances of NASH, COVID Vaccines and Real-World Data

Season 1 Episode 13

Reach us by sending a text

6 years, 4 months ago

Short Long
View Episode
Ep. 12 - Remdesivir's Price, RWD’s Moment & A Genomics Breakup
Ep. 12 - Remdesivir's Price, RWD’s Moment & A Genomics Breakup

Season 1 Episode 12

Reach us by sending a text

6 years, 4 months ago

Short Long
View Episode
Special Report: Lessons from the First Wave of COVID-19 Trials
Special Report: Lessons from the First Wave of COVID-19 Trials

Season 1

6 years, 4 months ago

Short Long
View Episode
Ep. 11 - Funding U.K. Biotechs, plus Global Vaccine Access
Ep. 11 - Funding U.K. Biotechs, plus Global Vaccine Access

Season 1 Episode 11

Reach us by sending a text

6 years, 4 months ago

Short Long
View Episode
Ep. 10 - EUAs, ACTIV & M&A
Ep. 10 - EUAs, ACTIV & M&A

Season 1 Episode 10

Reach us by sending a text

6 years, 5 months ago

Short Long
View Episode
Ep. 9 - IPOs, Vaccines & BIO's New Leader
Ep. 9 - IPOs, Vaccines & BIO's New Leader

Season 1 Episode 9

Reach us by sending a text

6 years, 5 months ago

Short Long
View Episode
Ep. 8 - Financing Flurry & Purchasing Pools
Ep. 8 - Financing Flurry & Purchasing Pools

Season 1 Episode 8

Reach us by sending a text

6 years, 5 months ago

Short Long
View Episode
Special Report: 'A Science Problem We Can Solve' with George Scangos and Hal Barron
Special Report: 'A Science Problem We Can Solve' with George Scangos and Hal Barron

Season 1

6 years, 5 months ago

Short Long
View Episode
Ep. 7 - FDA takes on COVID-19, plus ASCO's breakthroughs
Ep. 7 - FDA takes on COVID-19, plus ASCO's breakthroughs

Season 1 Episode 7

Reach us by sending a text

6 years, 5 months ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us